Reversing PD-1 Resistance in B16F10 Cells and Recovering Tumour Immunity Using a COX2 Inhibitor

por Pi, Chenyu, Jing, Ping, Li, Bingyu, Feng, Yan, Xu, Lijun, Xie, Kun, Huang, Tao, Xu, Xiaoqing, Gu, Hua, Fang, Jianmin
Publicado 2022

Neo-intline: integrated pipeline enables neoantigen design through the in-silico presentation of T-cell epitope

por Li, Bingyu, Jing, Ping, Zheng, Genhui, Pi, Chenyu, Zhang, Lu, Yin, Zuojing, Xu, Lijun, Qiu, Jingxuan, Gu, Hua, Qiu, Tianyi, Fang, Jianmin
Publicado 2023

A Novel Anti-B7-H3 × Anti-CD3 Bispecific Antibody with Potent Antitumor Activity

por Feng, Yan, Xie, Kun, Yin, Yanxin, Li, Bingyu, Pi, Chenyu, Xu, Xiaoqing, Huang, Tao, Zhang, Jingming, Wang, Bo, Gu, Hua, Fang, Jianmin
Publicado 2022

Targeting CD89 on tumor-associated macrophages overcomes resistance to immune checkpoint blockade

por Xu, Lijun, Li, Bingyu, Pi, Chenyu, Zhu, Zhaohua, Tao, Fei, Xie, Kun, Feng, Yan, Xu, Xiaoqing, Yin, Yanxin, Gu, Hua, Fang, Jianmin
Publicado 2022

Simultaneous exposure to FcγR and FcαR on monocytes and macrophages enhances antitumor activity in vivo

por Li, Bingyu, Xu, Lijun, Tao, Fei, Xie, Kun, Wu, Zhiqiang, Li, You, Li, Jie, Chen, Kaiming, Pi, Chenyu, Mendelsohn, Andrew, Larrick, James W., Gu, Hua, Fang, Jianmin
Publicado 2017